Regeneron (NASDAQ: REGN) reported Q1 EPS of $8.22, $0.26 worse than the analyst estimate of $8.48. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $3.24 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.